Associate Professor Sallie-Anne Pearson

BSc (Hons) PhD
Head, Pharmacoepidemiology and Pharmaceutical Policy Research Group

Telephone +61 2 9036 7023
Fax +61 2 9351 4391

Map

Biographical details

Sallie is a health service researcher and behavioural scientist with more than 15 years of experience in quality use of medicines research. Her interests include prescriber behaviour change, post-market surveillance of medicines and evaluating the impact of pharmaceutical policy interventions. Sallie completed her doctoral training at the University of Newcastle, Australia (1998) and her Postdoctoral Fellowship in Pharmaceutical Policy at Harvard Medical School (2000-2001). On her return to Australia she worked as a consultant to the WHO Collaborating Centre in Pharmaceutical Policy Boston and Medicare Australia. She established the Pharmacoepidemiology and Pharmaceutical Policy Research Group in 2006 and joined the Faculty of Pharmacy, University of Sydney in 2012. She is currently a Cancer Institute NSW Career Development Fellow.

Research interests

  • Quality use of medicines
  • Pharmacoepidemiology
  • Health Services Research
  • Clinician Behaviour Change
  • Cancer

Associations

  • Chair, NSW Health and Cancer Institute NSW, Population & Health Services Research Ethics Committee
  • Chair, National Prescribing Service: MedicineInsight Data Governance Expert Reference Group
  • Member, Drug Utilisation Sub-Committee of the Pharmaceutical Benefits Advisory Committee
  • Member, NSW Translational Bioinformatics Working Group
  • Member, Sydney Catalyst Translational Cancer Research Consortium: T2 Working Group
  • Member, Cancer Research Network, University of Sydney
  • Member, Centre for Disability Research, Management Committee, Faculty of Health Sciences, University of Sydney
  • Member, Health Data Linkage Group, The University of Sydney
  • Member, Cancer Research Economics Support Team (CREST)
  • Member, Health Service Research Association of Australia and New Zealand
  • Member, International Society of Pharmacoepidemiology
  • Member, Harvard Club of Australia

Keywords

Ageing

Selected grants

2014

  • The 'Optimise' study; Trevena L, Emery J, Dowie J, Pearson S, Rothwell P, Pignone M, Olver I, Tofler G, Barnes E; National Health and Medical Research Council (NHMRC)/Project Grants.
  • Centre of Research Excellence in Medicines and Ageing; McLachlan A, Pearson S, Banks E, Preen D, Le Couteur D, Dobbins T, Etherton-Beer C, Buckley N, Viney R, Henry D; National Health and Medical Research Council (NHMRC)/Centres of Research Excellence.

2013

  • The use and impact of high cost targeted cancer medicines: theory and reality; Pearson S, Ward R, Dobbins T, Lu C; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • The health system impact of mental illness in patients with chronic physical diseases: A capacity building project; Langton J, Dobbins T, Pearson S, Soumerai S, Lu C; DVC International/IPDF Grant.
  • Post-market surveillance of cancer medicines: Generating evidence for clinical and policy practice using linked health administrative data; Pearson S; Cancer Institute New South Wales/Career Development Fellowship.

2012

  • Should I take low dose aspirin? Development of the 'Optimise' decision aid for cancer chemoprophylaxis; Trevena L, Dowie J, Pearson S, Howard K, Olver I, Zannino D; Sydney Catalyst Translational Cancer Research/Pilot and Seed Funding.
  • High risk prescribing in older Australians; Banks E, Le Couteur D, Pearson S, McLachlan A, Viney R, Hilmer S, Gnjidic D, Blyth F; National Health and Medical Research Council (NHMRC)/Project Grants.
  • The health system impact of mental illness in patients with chronic disease: A capacity building project; Langton J, Pearson S; University of Sydney/International Program Development Fund.

2011

  • Validation of upper gastro-intestinal cancer surgical procedural and diagnostic codes in NSW; Stavrou E, Pearson S; Cancer Institute New South Wales/Research Grant.
  • Health service utilisation and risk factors for cancer of unknown primary (CUP); Pearson S; Cancer Institute New South Wales/Research Grant.

2010

  • Measuring the use and impact of the Cancer Institute Standard Cancer Treatments Program in NSW hospitals; Pearson S, Ward R; Cancer Institute New South Wales/Translational Health Services Research Grant.
  • The use, effectiveness and safety of cancer medicines in the real world clinical setting; Pearson S; Cancer Institute New South Wales/Career Development Fellowship.

2009

  • The use of and impact of cancer medicines in real world clinical practice: Evaluation in a cohort of elderly Australians; Pearson S, Ward R; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.
  • Building capacity in innovative approaches to health technology assessment; Viney R, Haas M, Pearson S, van Gool K; National Health and Medical Research Council (NHMRC)/Strategic Awards: Capacity Building Grants for Health Services Research.
  • Measuring the use and impact of the Cancer Institute NSW Standard treatments program in NSW hospitals: Developing and validating indicators; Pearson S; Cancer Institute New South Wales/Research Innovation Grants.

2008

  • Establishment of a network to investigate new and emerging cancer therapies; Ward R, Pearson S, Haas M, O'Connell D, McKinnon R, Henry D, Lassare M, Knight R, Messer M; National Health and Medical Research Council (NHMRC)/Project Grants.

2007

  • Using clinical and economic evidence to inform local decision making in cancer care; Ward R, Haas M, Pearson S, van Gool K; National Health and Medical Research Council (NHMRC)/Strategic Awards: Capacity Building Grants for Health Services Research.

2006

  • Interventions designed to maximise utilisation of the Cancer Institute NSW Standardised Treatment Program: Impact on clinical practice and patient outcomes; Pearson S; Cancer Institute New South Wales/Health Services Research Fellowship.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Langton, J., Pearson, S. (2014). Electronic Decision Support Systems for Prescribing: Challenges and Perspectives for Personalized Medicine. In Ioannis S. Vizirianakis (Eds.), Handbook of Personalized Medicine: Advances in Nanotechnology, Drug Delivery and Therapy, (pp. 1439-1472). Singapore: Pan Stanford Publishing.

Journals

  • Parkinson, B., Pearson, S., Viney, R. (2014). Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique. The European Journal of Health Economics, 15(1), 93-112. [More Information]
  • Reekie, J., Donovan, B., Guy, R., Hocking, J., Jorm, L., Kaldor, J., Mak, D., Preen, D., Pearson, S., Roberts, C., et al (2014). Hospitalisations for Pelvic Inflammatory Disease Temporally Related to a Diagnosis of Chlamydia or Gonorrhoea: A Retrospective Cohort Study. PLoS One, 9(4), 1-7. [More Information]
  • Vajdic, C., Stavrou, E., Ward, R., Falster, M., Pearson, S. (2014). Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study. Australian and New Zealand Journal of Public Health, 38(1), 30-34. [More Information]
  • Vajdic, C., Stavrou, E., Ward, R., Falster, M., Pearson, S. (2014). Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: a record linkage study. Australian and New Zealand Journal of Public Health, 38(1), 30-34. [More Information]
  • Gnjidic, D., Pearson, S., Hilmer, S. (2014). Optimizing the Impact of Drugs on Symptom Burden in Older PeopleWith Multimorbidity at the End of Life. JAMA Internal Medicine, 174(4), 636-637.
  • Pearson, S., Schaffer, A. (2014). The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians. BMJ Open, 4(5), 1-13. [More Information]
  • Srasuebkul, P., Dobbins, T., Pearson, S. (2014). Validation of a proxy for estrogen receptor status in breast cancer patients using dispensing data. Asia-Pacific Journal of Clinical Oncology, 10(2), e63-e68. [More Information]
  • Lu, C., Pearson, S. (2013). Author reply. Internal Medicine Journal, 43(5), 611-611. [More Information]
  • Gnjidic, D., Le Couteur, D., Pearson, S., McLachlan, A., Viney, R., Hilmer, S., Blyth, F., Joshy, G., Banks, E. (2013). High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health, 13, 1-9. [More Information]
  • Langton, J., Blanch, B., Pesa, N., Pearson, S., Park, J. (2013). How do medical doctors use a web-based oncology protocol system? A comparison of Australian doctors at different levels of medical training using logfile analysis and an online survey. BMC Medical Informatics and Decision Making, 13(1), 1-11. [More Information]
  • Lu, C., Srasuebkul, P., Drew, A., Chen, K., Ward, R., Pearson, S. (2013). Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function? The Breast, 22(4), 482-487. [More Information]
  • Langton, J., Pesa, N., Rushton, S., Ward, R., Pearson, S. (2013). Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online? BMC Cancer, 13, 1-9. [More Information]
  • Banks, E., Pearson, S. (2012). A life-cycle approach to monitoring benefits and harms of medicines: Collection of high-quality data and management of risk are ongoing needs. Medical Journal of Australia, 197(6), 313-314. [More Information]
  • Cohen, S., Lawson, J., Graudins, L., Pearson, S., Gazarian, M. (2012). Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality Use of Medicines. Journal of Paediatrics and Child Health, 48(6), 490-495. [More Information]
  • Haywood, P., de Raad, J., van Gool, K., Haas, M., Gallego, G., Pearson, S., Faedo, M., Ward, R. (2012). Chemotherapy administration: Modelling the costs of alternative protocols. PharmacoEconomics, 30(12), 1173-1186. [More Information]
  • Stavrou, E., Buckley, N., Olivier, J., Pearson, S. (2012). Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. BMJ Open, 2(3), 1-6. [More Information]
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2012). Governance approval for multisite, non-interventional research: what can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience? Internal Medicine Journal, 42(2), 127-131. [More Information]
  • Stavrou, E., Pesa, N., Pearson, S. (2012). Hospital discharge diagnostic and procedure codes for upper gastro-intestinal cancer: how accurate are they? BMC Health Services Research, 12(1), 1-7. [More Information]
  • Hains, I., Ward, R., Pearson, S. (2012). Implementing a web-based oncology protocol system in Australia: evaluation of the first 3 years of operation. Internal Medicine Journal, 42(1), 57-64. [More Information]
  • Langton, J., Pearson, S. (2012). Improving the quality of oncology guidelines and protocols. Asia-Pacific Journal of Clinical Oncology, 8(3), 313-313. [More Information]
  • Stavrou, E., Ward, R., Pearson, S. (2012). Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data. BMC Health Services Research, 12(1), 1-10. [More Information]
  • Robertson, J., McElduff, P., Pearson, S., Henry, D., Inder, K., Attia, J. (2012). The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Services Research, 12, 1-11. [More Information]
  • Stavrou, E., Lu, C., Buckley, N., Pearson, S. (2012). The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients. Annals of Oncology, 23(9), 2422-2428. [More Information]
  • Mealing, N., Dobbins, T., Pearson, S. (2012). Validation and application of the death proxy in adult cancer patients. Pharmacoepidemiology and Drug Safety: an international journal, 21(7), 742-748. [More Information]
  • Robertson, J., Moxey, A., Newby, D., Gillies, M., Williamson, M., Pearson, S. (2011). Electronic information and clinical decision support for prescribing: State of play in Australian general practice. Journal Of Family Practice, 28(1), 93-101. [More Information]
  • Langton, J., Pearson, S. (2011). eviQ cancer treatments online: How does the web-based protocol system fare in a comprehensive quality assessment? Asia-Pacific Journal of Clinical Oncology, 7(4), 357-363. [More Information]
  • Lu, C., Srasuebkul, P., Drew, A., Ward, R., Pearson, S. (2011). Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Internal Medicine Journal, (Online preview)(11), 1229-1235. [More Information]
  • Harris, C., Ward, R., Dobbins, T., Drew, A., Pearson, S. (2011). The efficacy of HER2 targeted agents in metastatic breast cancer: A meta-analysis. Annals of Oncology, 22, 1308-1317. [More Information]
  • Langton, J., Drew, A., Mellish, L., Olivier, J., Ward, R., Pearson, S. (2011). The quality of web-based oncology guidelines and protocols: how do international sites stack up? British Journal of Cancer, 105(8), 1166-1172. [More Information]
  • Stavrou, E., Vagdic, C., Loxton, D., Pearson, S. (2011). The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiology, 35, e75-e80. [More Information]
  • Moxey, A., Robertson, J., Newby, D., Hains, I., Williamson, M., Pearson, S. (2010). Computerized clinical decision support for prescribing: provision does not guarantee uptake. Journal of the American Medical Informatics Association, 17(1), 25-33. [More Information]
  • de Raad, J., van Gool, K., Haas, M., Haywood, P., Faedo, M., Gallego, G., Pearson, S., Ward, R. (2010). Nursing takes time: workload associated with administering cancer protocols. Clinical Journal of Oncology Nursing, 14(6), 735-741. [More Information]
  • Pearson, S., Chin, M., Faedo, M., Ward, R. (2010). Rationale for treatment durations of targeted cancer agents. The Lancet Oncology, 11(12), 1113-1115. [More Information]
  • Robertson, J., Walkom, E., Pearson, S., Hains, I., Williamsone, M., Newby, D. (2010). The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. International Journal of Pharmacy Practice, 18(2), 69-87. [More Information]
  • Pearson, S., Moxey, A., Robertson, J., Hains, I., Williamson, M., Reeve, J., Newby, D. (2009). Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Services Research, 9, 1-14. [More Information]
  • Garvey, G., Rolfe, I., Pearson, S., Treloar, C. (2009). Indigenous Australian medical students' perceptions of their medical school training. Medical Education, 43(11), 1047-1055. [More Information]
  • Hains, I., Fuller, J., Ward, R., Pearson, S. (2009). Standardizing care in medical oncology: Are web-based systems the answer? Cancer, 115(23), 5579-5588. [More Information]
  • Lane, C., Healy, C., Ho, M., Pearson, S., Brown, M. (2008). How to attract a nephrology trainee: Quantitative questionnaire results. Nephrology, 13(2), 116-123. [More Information]
  • Lu, C., Ross-Degnan, D., Soumerai, S., Pearson, S. (2008). Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Services Research, 8, 1-12. [More Information]
  • Ringland, C., Mant, A., McGettigan, P., Mitchell, P., Kelman, C., Buckley, N., Pearson, S. (2008). Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data. British Journal of Clinical Pharmacology, 66(5), 682-688. [More Information]
  • Kelman, C., Pearson, S., Day, R., Holman, C., Kliewer, E., Henry, D. (2007). Evaluating Medicines: let's use all the evidence. Internal Medicine Journal, 186(5), 249-252.
  • Pearson, S., Ringland, C., Kelman, C., Mant, J., Lowinger, J., Stark, H., Nichol, G., Day, R., Henry, D. (2007). Patterns of analgesic and anti-inflammatory medicine use by Australian veterans. Internal Medicine Journal, 37(12), 798-805. [More Information]
  • Pearson, S., Ringland, C., Ward, R. (2007). Trastuzumab and metastatic breast cancer: Trastuzumab use in Australia - Monitoring the effect of an expensive medicine access program. Journal of Clinical Oncology, 25(24), 3688-3693. [More Information]
  • Pearson, S., Ringland, C., Ward, R. (2007). Use of Trastuzumab for metastatic breast cancer in Australia: interpreting findings from a cohort of 1,469 women on a national access program versus 41 women treated by two medical oncologists. Journal of Clinical Oncology, 25(35), 5663-5664. [More Information]
  • Tan, E., Stark, H., Lowinger, J., Ringland, C., Ward, R., Pearson, S. (2006). Information Sources used by New South Wales cancer clinicians: a qualitative study. Internal Medicine Journal, 36(11), 711-717. [More Information]
  • Pearson, S., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L., Fanning, T., Gallagher, P., Ross-Degnan, D. (2006). Racial disparities in access after regulatory surveillance of benzodiazepines. Archives of Internal Medicine, 166(5), 572-579. [More Information]
  • Rolfe, I., Ringland, C., Pearson, S. (2004). Graduate entry to medical school? Testing some assumptions. Medical Education, 38(7), 778-786. [More Information]
  • Pearson, S., Ross-Degnan, D., Payson, A., Soumerai, S. (2003). Changing medication use in managed care: A critical review of the available evidence. American Journal of Managed Care, 9(11), 715-731.
  • Pearson, S., Rolfe, I., Ringland, C., Kay-Lambkin, F. (2002). A comparison of practice outcomes of graduates from traditional and non-traditional medical schools in Australia. Medical Education, 36(10), 985-991. [More Information]
  • Pearson, S., Rolfe, I., Smith, T. (2002). Factors influencing prescribing: An intern's perspective. Medical Education, 36(8), 781-787.
  • Pearson, S., Rolfe, I., Smith, T., O'Connell, D. (2002). Intern prescribing decisions: Few and far between. Education for Health, 15(3), 315-325. [More Information]
  • Mooney, W., Cole, I., Albsoul, N., Pearson, S. (2002). Salvage vertical partial laryngectomy for radiation failure in early glottic carcinoma. ANZ Journal of Surgery, 72(10), 746-749. [More Information]
  • Kay-Lambkin, F., Pearson, S., Rolfe, I. (2002). The influence of admissions variables on first year medical school performance: A study from Newcastle University. Medical Education, 36(2), 154-159. [More Information]
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C., Bayley, S., Hart, A., Kelly, S. (2002). Which common clinical conditions should medical students be able to manage by graduation? A perspective from Australian interns. Medical Teacher, 24(1), 16-22.
  • Grey, M., Pearson, S., Rolfe, I., Kay, F., Powis, D. (2001). How do australian doctors with different pre-medical school backgrounds perform as interns? Education for Health, 14(1), 87-96.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C. (2001). Identifying medical school learning needs: A survey of Australian interns. Education for Health, 14(3), 395-404. [More Information]
  • Clercq, L., Pearson, S., Rolfe, I. (2001). The relationship between previous tertiary education and course performance in first year medical students at Newcastle University. Education for Health, 14(3), 417-426.
  • Garvey, G., Rolfe, I., Pearson, S. (2000). Agents for social change: The University of Newcastle's role in graduating Australian Aboriginal doctors. Focus on Health Professional Education: a multi-disciplinary journal, 2(2), 18-27.
  • Treloar, C., McCall, N., Rolfe, I., Pearson, S., Garvey, G., Heathcote, A. (2000). Factors affecting progress of Australian and international students in a prolem-based learning medical course. Medical Education, 34(9), 708-715.
  • Pearson, S., Smith, A., Rolfe, I., Moulds, R., Shenfield, G. (2000). Intern prescribing for common clinical conditions. Advances in Health Sciences Education, 5(2), 141-150.
  • Enno, A., Mondy, P., Kerridge, R., Pearson, S. (2000). Investigating pathology utilisation by junior medical staff in a teaching hospital: a qualitative study. Australian and New Zealand Journal of Medicine, 30(2), 261-263.

2014

  • Parkinson, B., Pearson, S., Viney, R. (2014). Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique. The European Journal of Health Economics, 15(1), 93-112. [More Information]
  • Langton, J., Pearson, S. (2014). Electronic Decision Support Systems for Prescribing: Challenges and Perspectives for Personalized Medicine. In Ioannis S. Vizirianakis (Eds.), Handbook of Personalized Medicine: Advances in Nanotechnology, Drug Delivery and Therapy, (pp. 1439-1472). Singapore: Pan Stanford Publishing.
  • Reekie, J., Donovan, B., Guy, R., Hocking, J., Jorm, L., Kaldor, J., Mak, D., Preen, D., Pearson, S., Roberts, C., et al (2014). Hospitalisations for Pelvic Inflammatory Disease Temporally Related to a Diagnosis of Chlamydia or Gonorrhoea: A Retrospective Cohort Study. PLoS One, 9(4), 1-7. [More Information]
  • Vajdic, C., Stavrou, E., Ward, R., Falster, M., Pearson, S. (2014). Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: A record linkage study. Australian and New Zealand Journal of Public Health, 38(1), 30-34. [More Information]
  • Vajdic, C., Stavrou, E., Ward, R., Falster, M., Pearson, S. (2014). Minimal excess risk of cancer and reduced risk of death from cancer in Australian Department of Veterans' Affairs clients: a record linkage study. Australian and New Zealand Journal of Public Health, 38(1), 30-34. [More Information]
  • Gnjidic, D., Pearson, S., Hilmer, S. (2014). Optimizing the Impact of Drugs on Symptom Burden in Older PeopleWith Multimorbidity at the End of Life. JAMA Internal Medicine, 174(4), 636-637.
  • Pearson, S., Schaffer, A. (2014). The use and impact of cancer medicines in routine clinical care: methods and observations in a cohort of elderly Australians. BMJ Open, 4(5), 1-13. [More Information]
  • Srasuebkul, P., Dobbins, T., Pearson, S. (2014). Validation of a proxy for estrogen receptor status in breast cancer patients using dispensing data. Asia-Pacific Journal of Clinical Oncology, 10(2), e63-e68. [More Information]

2013

  • Lu, C., Pearson, S. (2013). Author reply. Internal Medicine Journal, 43(5), 611-611. [More Information]
  • Gnjidic, D., Le Couteur, D., Pearson, S., McLachlan, A., Viney, R., Hilmer, S., Blyth, F., Joshy, G., Banks, E. (2013). High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level. BMC Public Health, 13, 1-9. [More Information]
  • Langton, J., Blanch, B., Pesa, N., Pearson, S., Park, J. (2013). How do medical doctors use a web-based oncology protocol system? A comparison of Australian doctors at different levels of medical training using logfile analysis and an online survey. BMC Medical Informatics and Decision Making, 13(1), 1-11. [More Information]
  • Lu, C., Srasuebkul, P., Drew, A., Chen, K., Ward, R., Pearson, S. (2013). Trastuzumab therapy in Australia: Which patients with HER2+ metastatic breast cancer are assessed for cardiac function? The Breast, 22(4), 482-487. [More Information]
  • Langton, J., Pesa, N., Rushton, S., Ward, R., Pearson, S. (2013). Uptake of a web-based oncology protocol system: how do cancer clinicians use eviQ cancer treatments online? BMC Cancer, 13, 1-9. [More Information]

2012

  • Banks, E., Pearson, S. (2012). A life-cycle approach to monitoring benefits and harms of medicines: Collection of high-quality data and management of risk are ongoing needs. Medical Journal of Australia, 197(6), 313-314. [More Information]
  • Cohen, S., Lawson, J., Graudins, L., Pearson, S., Gazarian, M. (2012). Changes in Anticonvulsant Prescribing for Australian Children: Implications for Quality Use of Medicines. Journal of Paediatrics and Child Health, 48(6), 490-495. [More Information]
  • Haywood, P., de Raad, J., van Gool, K., Haas, M., Gallego, G., Pearson, S., Faedo, M., Ward, R. (2012). Chemotherapy administration: Modelling the costs of alternative protocols. PharmacoEconomics, 30(12), 1173-1186. [More Information]
  • Stavrou, E., Buckley, N., Olivier, J., Pearson, S. (2012). Discontinuation of statin therapy in older people: does a cancer diagnosis make a difference? An observational cohort study using data linkage. BMJ Open, 2(3), 1-6. [More Information]
  • Vajdic, C., Meagher, N., Hicks, S., Faedo, M., Ward, R., Pearson, S. (2012). Governance approval for multisite, non-interventional research: what can Harmonisation of Multi-Centre Ethical Review learn from the New South Wales experience? Internal Medicine Journal, 42(2), 127-131. [More Information]
  • Stavrou, E., Pesa, N., Pearson, S. (2012). Hospital discharge diagnostic and procedure codes for upper gastro-intestinal cancer: how accurate are they? BMC Health Services Research, 12(1), 1-7. [More Information]
  • Hains, I., Ward, R., Pearson, S. (2012). Implementing a web-based oncology protocol system in Australia: evaluation of the first 3 years of operation. Internal Medicine Journal, 42(1), 57-64. [More Information]
  • Langton, J., Pearson, S. (2012). Improving the quality of oncology guidelines and protocols. Asia-Pacific Journal of Clinical Oncology, 8(3), 313-313. [More Information]
  • Stavrou, E., Ward, R., Pearson, S. (2012). Oesophagectomy rates and post-resection outcomes in patients with cancer of the oesophagus and gastro-oesophageal junction: a population-based study using linked health administrative linked data. BMC Health Services Research, 12(1), 1-10. [More Information]
  • Robertson, J., McElduff, P., Pearson, S., Henry, D., Inder, K., Attia, J. (2012). The health services burden of heart failure: an analysis using linked population health data-sets. BMC Health Services Research, 12, 1-11. [More Information]
  • Stavrou, E., Lu, C., Buckley, N., Pearson, S. (2012). The role of comorbidities on the uptake of systemic treatment and 3-year survival in older cancer patients. Annals of Oncology, 23(9), 2422-2428. [More Information]
  • Mealing, N., Dobbins, T., Pearson, S. (2012). Validation and application of the death proxy in adult cancer patients. Pharmacoepidemiology and Drug Safety: an international journal, 21(7), 742-748. [More Information]

2011

  • Robertson, J., Moxey, A., Newby, D., Gillies, M., Williamson, M., Pearson, S. (2011). Electronic information and clinical decision support for prescribing: State of play in Australian general practice. Journal Of Family Practice, 28(1), 93-101. [More Information]
  • Langton, J., Pearson, S. (2011). eviQ cancer treatments online: How does the web-based protocol system fare in a comprehensive quality assessment? Asia-Pacific Journal of Clinical Oncology, 7(4), 357-363. [More Information]
  • Lu, C., Srasuebkul, P., Drew, A., Ward, R., Pearson, S. (2011). Positive spillover effects of prescribing requirements: Increased cardiac testing in patients treated with trastuzumab for HER2+ metastatic breast cancer. Internal Medicine Journal, (Online preview)(11), 1229-1235. [More Information]
  • Harris, C., Ward, R., Dobbins, T., Drew, A., Pearson, S. (2011). The efficacy of HER2 targeted agents in metastatic breast cancer: A meta-analysis. Annals of Oncology, 22, 1308-1317. [More Information]
  • Langton, J., Drew, A., Mellish, L., Olivier, J., Ward, R., Pearson, S. (2011). The quality of web-based oncology guidelines and protocols: how do international sites stack up? British Journal of Cancer, 105(8), 1166-1172. [More Information]
  • Stavrou, E., Vagdic, C., Loxton, D., Pearson, S. (2011). The validity of self-reported cancer diagnoses and factors associated with accurate reporting in a cohort of older Australian women. Cancer Epidemiology, 35, e75-e80. [More Information]

2010

  • Moxey, A., Robertson, J., Newby, D., Hains, I., Williamson, M., Pearson, S. (2010). Computerized clinical decision support for prescribing: provision does not guarantee uptake. Journal of the American Medical Informatics Association, 17(1), 25-33. [More Information]
  • de Raad, J., van Gool, K., Haas, M., Haywood, P., Faedo, M., Gallego, G., Pearson, S., Ward, R. (2010). Nursing takes time: workload associated with administering cancer protocols. Clinical Journal of Oncology Nursing, 14(6), 735-741. [More Information]
  • Pearson, S., Chin, M., Faedo, M., Ward, R. (2010). Rationale for treatment durations of targeted cancer agents. The Lancet Oncology, 11(12), 1113-1115. [More Information]
  • Robertson, J., Walkom, E., Pearson, S., Hains, I., Williamsone, M., Newby, D. (2010). The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. International Journal of Pharmacy Practice, 18(2), 69-87. [More Information]

2009

  • Pearson, S., Moxey, A., Robertson, J., Hains, I., Williamson, M., Reeve, J., Newby, D. (2009). Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Services Research, 9, 1-14. [More Information]
  • Garvey, G., Rolfe, I., Pearson, S., Treloar, C. (2009). Indigenous Australian medical students' perceptions of their medical school training. Medical Education, 43(11), 1047-1055. [More Information]
  • Hains, I., Fuller, J., Ward, R., Pearson, S. (2009). Standardizing care in medical oncology: Are web-based systems the answer? Cancer, 115(23), 5579-5588. [More Information]

2008

  • Lane, C., Healy, C., Ho, M., Pearson, S., Brown, M. (2008). How to attract a nephrology trainee: Quantitative questionnaire results. Nephrology, 13(2), 116-123. [More Information]
  • Lu, C., Ross-Degnan, D., Soumerai, S., Pearson, S. (2008). Interventions designed to improve the quality and efficiency of medication use in managed care: a critical review of the literature - 2001-2007. BMC Health Services Research, 8, 1-12. [More Information]
  • Ringland, C., Mant, A., McGettigan, P., Mitchell, P., Kelman, C., Buckley, N., Pearson, S. (2008). Uncovering the potential risk of serotonin toxicity in Australian veterans using pharmaceutical claims data. British Journal of Clinical Pharmacology, 66(5), 682-688. [More Information]

2007

  • Kelman, C., Pearson, S., Day, R., Holman, C., Kliewer, E., Henry, D. (2007). Evaluating Medicines: let's use all the evidence. Internal Medicine Journal, 186(5), 249-252.
  • Pearson, S., Ringland, C., Kelman, C., Mant, J., Lowinger, J., Stark, H., Nichol, G., Day, R., Henry, D. (2007). Patterns of analgesic and anti-inflammatory medicine use by Australian veterans. Internal Medicine Journal, 37(12), 798-805. [More Information]
  • Pearson, S., Ringland, C., Ward, R. (2007). Trastuzumab and metastatic breast cancer: Trastuzumab use in Australia - Monitoring the effect of an expensive medicine access program. Journal of Clinical Oncology, 25(24), 3688-3693. [More Information]
  • Pearson, S., Ringland, C., Ward, R. (2007). Use of Trastuzumab for metastatic breast cancer in Australia: interpreting findings from a cohort of 1,469 women on a national access program versus 41 women treated by two medical oncologists. Journal of Clinical Oncology, 25(35), 5663-5664. [More Information]

2006

  • Tan, E., Stark, H., Lowinger, J., Ringland, C., Ward, R., Pearson, S. (2006). Information Sources used by New South Wales cancer clinicians: a qualitative study. Internal Medicine Journal, 36(11), 711-717. [More Information]
  • Pearson, S., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L., Fanning, T., Gallagher, P., Ross-Degnan, D. (2006). Racial disparities in access after regulatory surveillance of benzodiazepines. Archives of Internal Medicine, 166(5), 572-579. [More Information]

2004

  • Rolfe, I., Ringland, C., Pearson, S. (2004). Graduate entry to medical school? Testing some assumptions. Medical Education, 38(7), 778-786. [More Information]

2003

  • Pearson, S., Ross-Degnan, D., Payson, A., Soumerai, S. (2003). Changing medication use in managed care: A critical review of the available evidence. American Journal of Managed Care, 9(11), 715-731.

2002

  • Pearson, S., Rolfe, I., Ringland, C., Kay-Lambkin, F. (2002). A comparison of practice outcomes of graduates from traditional and non-traditional medical schools in Australia. Medical Education, 36(10), 985-991. [More Information]
  • Pearson, S., Rolfe, I., Smith, T. (2002). Factors influencing prescribing: An intern's perspective. Medical Education, 36(8), 781-787.
  • Pearson, S., Rolfe, I., Smith, T., O'Connell, D. (2002). Intern prescribing decisions: Few and far between. Education for Health, 15(3), 315-325. [More Information]
  • Mooney, W., Cole, I., Albsoul, N., Pearson, S. (2002). Salvage vertical partial laryngectomy for radiation failure in early glottic carcinoma. ANZ Journal of Surgery, 72(10), 746-749. [More Information]
  • Kay-Lambkin, F., Pearson, S., Rolfe, I. (2002). The influence of admissions variables on first year medical school performance: A study from Newcastle University. Medical Education, 36(2), 154-159. [More Information]
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C., Bayley, S., Hart, A., Kelly, S. (2002). Which common clinical conditions should medical students be able to manage by graduation? A perspective from Australian interns. Medical Teacher, 24(1), 16-22.

2001

  • Grey, M., Pearson, S., Rolfe, I., Kay, F., Powis, D. (2001). How do australian doctors with different pre-medical school backgrounds perform as interns? Education for Health, 14(1), 87-96.
  • Rolfe, I., Pearson, S., Sanson-Fisher, R., Ringland, C. (2001). Identifying medical school learning needs: A survey of Australian interns. Education for Health, 14(3), 395-404. [More Information]
  • Clercq, L., Pearson, S., Rolfe, I. (2001). The relationship between previous tertiary education and course performance in first year medical students at Newcastle University. Education for Health, 14(3), 417-426.

2000

  • Garvey, G., Rolfe, I., Pearson, S. (2000). Agents for social change: The University of Newcastle's role in graduating Australian Aboriginal doctors. Focus on Health Professional Education: a multi-disciplinary journal, 2(2), 18-27.
  • Treloar, C., McCall, N., Rolfe, I., Pearson, S., Garvey, G., Heathcote, A. (2000). Factors affecting progress of Australian and international students in a prolem-based learning medical course. Medical Education, 34(9), 708-715.
  • Pearson, S., Smith, A., Rolfe, I., Moulds, R., Shenfield, G. (2000). Intern prescribing for common clinical conditions. Advances in Health Sciences Education, 5(2), 141-150.
  • Enno, A., Mondy, P., Kerridge, R., Pearson, S. (2000). Investigating pathology utilisation by junior medical staff in a teaching hospital: a qualitative study. Australian and New Zealand Journal of Medicine, 30(2), 261-263.

To update your profile click here. For support on your academic profile contact .